ENvue Medical, Inc.
FEED- Exchange
- OTC
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001326706
No open-market purchases or sales by ENvue Medical, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $149.2K in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in ENvue Medical, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- +3 vs. Q1 2021
- Shares held
- 1.12M
- −28.8K (−2.5%) vs. Q1 2021
- Total value
- $954.1K
- −$216.9K (−18.5%) vs. Q1 2021
- New holders
- 3
- 5 more added
- Sold out
- 0
- 4 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FEED on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 13 | $149.2K |
| Q1 2026 | 13 | $179.2K |
| Q4 2025 | 6 | $42.5K |
| Q3 2025 | 6 | $9.50K |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 9 | $215.3K |
| Q3 2024 | 9 | $251.5K |
| Q2 2024 | 8 | $163.3K |
| Q1 2024 | 10 | $327.2K |
| Q4 2023 | 11 | $123.0K |
| Q3 2023 | 13 | $242.1K |
| Q2 2023 | 9 | $142.1K |
| Q1 2023 | 10 | $203.6K |
| Q4 2022 | 18 | $593.0K |
| Q3 2022 | 15 | $679.0K |
| Q2 2022 | 13 | $906.0K |
| Q1 2022 | 19 | $2.12M |
| Q4 2021 | 20 | $1.72M |
| Q3 2021 | 21 | $2.60M |
| Q2 2021 | 17 | $954.1K |
| Q1 2021 | 14 | $1.17M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding ENvue Medical, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 308,919 | $263.0K | 0.00% | +117,242+61.2% | Added |
| Amtrust Financial Services, Inc. | 146,148 | $124.0K | 0.09% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 136,884 | $116.0K | 0.00% | +37,501+37.7% | Added |
| Citadel Advisors LLC | 99,848 | $85.0K | 0.00% | −37,742−27.4% | Reduced |
| HighTower Advisors, LLC | 92,552 | $79.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 85,213 | $73.0K | 0.00% | −233,287−73.2% | Reduced |
| Virtu Financial LLC | 65,046 | $55.0K | 0.01% | +12,979+24.9% | Added |
| Northern Trust Corp | 46,869 | $40.0K | 0.00% | +27,826+146.1% | Added |
| State Street Corp | 41,590 | $35.0K | 0.00% | +41,590 | New |
| Plotkin Financial Advisors, LLC | 28,300 | $24.1K | 0.01% | +28,300 | New |
| UBS Group AG | 26,248 | $22.0K | 0.00% | −28,669−52.2% | Reduced |
| Two Sigma Advisers, LP | 20,500 | $17.0K | 0.00% | +5,500+36.7% | Added |
| Jacobi Capital Management LLC | 15,000 | $13.0K | 0.00% | 00.0% | Unchanged |
| Psagot Investment House Ltd. | 9,720 | $8.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 140 | $0 | 0.00% | −1−0.7% | Reduced |
| Tower Research Capital LLC (TRC) | 91 | $0 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 9 | $0 | 0.00% | +9 | New |